Overview
mRNA technology could be key to tackling cancer, respiratory diseases and latent viruses, says Moderna’s Stéphane Bancel.
![](https://www.bailliegifford.com/cdn-cgi/image/w=3840,h=2160,g=0.5x0.5,fit=cover/https://media.bailliegifford.com/mws/5kjdn3rd/podcast-player-image.jpg?v=63844382907)
mRNA technology could be key to tackling cancer, respiratory diseases and latent viruses, says Moderna’s Stéphane Bancel.